Construction and Preclinical Evaluation of <sup>124</sup>I/<sup>125</sup>I-Labeled Antibody Targeting T Cell Immunoglobulin and Mucin Domain-3
2024 · Molecular Pharmaceutics · 10 citations
https://doi.org/10.1021/acs.molpharmaceut.3c01046
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
575
Citations
11
h-index
13
i10-index
Ziqing Zeng is an academic researcher from Ministry of Education. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Lung Cancer Diagnosis and Treatment. The author has an h-index of 11, co-authored 23 publications.
https://doi.org/10.1021/acs.molpharmaceut.3c01046
https://doi.org/10.1016/j.biopha.2024.116669
Click to start Chat